Eli Lilly has morphed from a reliable pharma giant into a biotech powerhouse riding blockbuster success. Mounjaro and ...

FOR Hope Lancaster Colquhoun, her perfect smile had always been a source of pride – so it was a moment of pure horror when ...

The widespread hunt for candidates who are equally versed in tech and healthcare is making AI recruiting a challenge.

The Chicago native will screen the cult classic ‘Bound’ this week as part of Sapphopalooza. “Our films are remaining relevant ...

The stock's rise snapped a five-day losing streak.

Ignite’s home matches this year, partly through support from Lilly, the presenting sponsor of the team’s inaugural season.

Ive announced a $6.4 billion deal that will merge his io hardware firm with OpenAI. Ive will head up the design for a new ...

Eli Lilly has received approval in Australia to market its Alzheimer's treatment Kisunla. The pharmaceutical company said Wednesday the Australian Therapeutic Goods Administration granted marketing ...

The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to halt the sale and production of off-brand products that many patients in ...

Purdue University is launching new academic programs, expanding research capabilities and forging partnerships with one ...

Contrarian investing advice from biotech and pharmaceutical stock expert Hartaj Singh, Founding Partner of Tecumseh Partners ...

Analysts at BMO Capital Markets said in a weekend note that a non-invasive blood test could help boost uptake of Alzheimer’s ...